Roles of Histone Modifiers in Cancer and Neurodegeneration
Author Information
Author(s): Reed Lauren, Abraham Janak, Patel Shay, Dhar Shilpa S., Stoccoro Andrea
Primary Institution: The University of Texas MD Anderson Cancer Center
Hypothesis
This review aims to explore the roles of histone methyltransferases and demethylases in cancer and neurodegenerative diseases.
Conclusion
Histone modifiers play crucial roles in both cancer progression and neurodegenerative diseases, highlighting their potential as therapeutic targets.
Supporting Evidence
- Histone methyltransferases and demethylases regulate gene expression by adding or removing methyl groups on histones.
- Dysregulation of these enzymes is linked to various cancers and neurodegenerative diseases.
- Understanding the roles of these modifiers may reveal new therapeutic targets.
Takeaway
Histone modifiers are like tiny switches that can turn genes on or off, and they can cause problems in diseases like cancer and Alzheimer's if they don't work right.
Methodology
This is a review article summarizing existing research on histone modifiers in cancer and neurodegenerative diseases.
Limitations
The mechanisms of how histone modifiers contribute to these diseases are not fully understood.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website